Repligen Opens Training & Innovation Center to Elevate Customer Experience
Repligen (NASDAQ:RGEN) has announced the grand opening of its Repligen Training & Innovation Center (RTIC) at its Waltham headquarters. The 7,500 square foot facility is designed to provide customers with pre- and post-sales support and hands-on experience with Repligen's bioprocessing solutions. The RTIC features product exhibits, demonstration areas, and technical training space, showcasing Repligen's complete collection of bioprocessing technologies.
The center includes displays of upstream intensification technologies, downstream products, and integrated systems. It also highlights process analytics technologies and fluid management products. The RTIC aims to elevate customer experience through live engagement with subject matter experts and demonstrate Repligen's end-to-end capabilities.
In addition to the RTIC, Repligen has expanded its Waltham site to a total of 182,000 square feet and completed a site relocation and expansion in Jüri, Estonia, earlier this year. The Estonian facility is an 80,000 square foot, LEED Silver certified Customer Center of Excellence for advanced TFF and chromatography systems.
Repligen (NASDAQ:RGEN) ha annunciato l'apertura ufficiale del suo Repligen Training & Innovation Center (RTIC) presso la sua sede di Waltham. La struttura di 7.500 piedi quadrati è concepita per fornire supporto ai clienti prima e dopo la vendita, offrendo esperienze pratiche con le soluzioni di bioprocessing di Repligen. Il RTIC include esposizioni di prodotto, aree dimostrative e spazi per la formazione tecnica, mettendo in mostra l'intera collezione di tecnologie di bioprocessing di Repligen.
Il centro comprende esposizioni di tecnologie di intensificazione upstream, prodotti downstream e sistemi integrati. Sottolinea inoltre le tecnologie di analisi dei processi e i prodotti per la gestione dei fluidi. Il RTIC punta a migliorare l'esperienza del cliente attraverso il coinvolgimento diretto con esperti del settore e a dimostrare le capacità complete di Repligen.
In aggiunta al RTIC, Repligen ha ampliato il suo sito di Waltham a un totale di 182.000 piedi quadrati e ha completato una relocation e un'espansione a Jüri, Estonia, all'inizio di quest'anno. La struttura estone è un Customer Center of Excellence di 80.000 piedi quadrati, certificato LEED Silver, dedicato a sistemi avanzati di TFF e cromatografia.
Repligen (NASDAQ:RGEN) ha anunciado la gran apertura de su Repligen Training & Innovation Center (RTIC) en su sede de Waltham. La instalación de 7,500 pies cuadrados está diseñada para proporcionar a los clientes apoyo antes y después de la venta, así como experiencia práctica con las soluciones de bioprocesamiento de Repligen. El RTIC cuenta con exhibiciones de productos, áreas de demostración y espacio para capacitación técnica, que exhiben toda la colección de tecnologías de bioprocesamiento de Repligen.
El centro incluye exhibiciones de tecnologías de intensificación upstream, productos downstream y sistemas integrados. También destaca las tecnologías de análisis de procesos y los productos de gestión de fluidos. El RTIC tiene como objetivo mejorar la experiencia del cliente mediante un compromiso en vivo con expertos en la materia y demostrar las capacidades integrales de Repligen.
Además del RTIC, Repligen ha ampliado su sitio en Waltham a un total de 182,000 pies cuadrados y ha completado una reubicación y expansión en Jüri, Estonia, a principios de este año. La instalación estonia es un Centro de Excelencia para Clientes de 80,000 pies cuadrados, certificado LEED Silver para sistemas avanzados de TFF y cromatografía.
레프리겐(Repligen) (NASDAQ:RGEN)은 월섬 본사에 레프리겐 교육 및 혁신 센터(RTIC)의 개장을 발표했습니다. 이 7,500 평방 피트 규모의 시설은 고객에게 판매 전후 지원을 제공하고 레프리겐의 생물 처리 솔루션에 대한 실습 경험을 제공하도록 설계되었습니다. RTIC는 제품 전시, 시연 공간 및 기술 교육 공간을 갖추고 있으며, 레프리겐의 전체 생물 처리 기술을 선보이고 있습니다.
이 센터에는 업스트림 집약화 기술, 다운스트림 제품 및 통합 시스템 전시가 포함되어 있습니다. 또한 процесс 분석 기술과 유체 관리 제품을 강조합니다. RTIC는 주제 전문가와의 라이브 참여를 통해 고객 경험을 향상시키고 레프리겐의 종합적인 능력을 시연하는 것을 목표로 합니다.
RTIC 외에도 레프리겐은 월섬의 사이트를 총 182,000 평방 피트로 확장하였으며, 올해 초 에스토니아 유리에서 사이트 이전 및 확장을 완료했습니다. 에스토니아 시설은 80,000 평방 피트 규모로, 고급 TFF 및 크로마토그래피 시스템을 위한 LEED 실버 인증 고객 우수 센터입니다.
Repligen (NASDAQ:RGEN) a annoncé l'ouverture officielle de son Repligen Training & Innovation Center (RTIC) à son siège de Waltham. Le centre de 7 500 pieds carrés est conçu pour fournir aux clients un soutien avant et après-vente, ainsi qu'une expérience pratique des solutions de bioprocessing de Repligen. Le RTIC comprend des expositions de produits, des zones de démonstration et des espaces de formation technique, présentant l'ensemble de la collection de technologies de bioprocessing de Repligen.
Le centre inclut des présentations de technologies d'intensification en amont, de produits en aval et de systèmes intégrés. Il met également en avant des technologies d'analyse des processus et des produits de gestion des fluides. Le RTIC vise à améliorer l'expérience client grâce à un engagement direct avec des experts et à démontrer les capacités complètes de Repligen.
En plus du RTIC, Repligen a élargi son site de Waltham à un total de 182 000 pieds carrés et a terminé une relocalisation et une extension à Jüri, en Estonie, plus tôt cette année. L'installation estonienne est un Centre d'Excellence Client de 80 000 pieds carrés, certifié Silver LEED, dédié aux systèmes avancés de TFF et de chromatographie.
Repligen (NASDAQ:RGEN) hat die offizielle Eröffnung seines Repligen Training & Innovation Centers (RTIC) an seinem Hauptsitz in Waltham bekannt gegeben. Das 7.500 Quadratfuß große Gebäude ist so konzipiert, dass es Kunden vor und nach dem Verkauf Unterstützung und praktische Erfahrungen mit den Bioprozesslösungen von Repligen bietet. Das RTIC verfügt über Produktpräsentationen, Demonstrationsbereiche und technische Schulungsräume, die die gesamte Palette der Bioprozess-Technologien von Repligen präsentieren.
Das Zentrum umfasst Ausstellungen von Upstream-Intensifizierungstechnologien, Downstream-Produkten und integrierten Systemen. Es hebt auch Prozesseanalysetechnologien und Fluidmanagementprodukte hervor. Das RTIC zielt darauf ab, das Kundenerlebnis durch direkte Interaktion mit Fachexperten zu verbessern und die umfassenden Fähigkeiten von Repligen zu demonstrieren.
Zusätzlich zum RTIC hat Repligen seinen Standort in Waltham auf insgesamt 182.000 Quadratfuß erweitert und Anfang dieses Jahres eine Standortverlagerung und -erweiterung in Jüri, Estland, abgeschlossen. Die estnische Einrichtung ist ein 80.000 Quadratfuß großer, LEED-zertifizierter Silver Customer Center of Excellence für fortschrittliche TFF- und Chromatographiesysteme.
- Opening of 7,500 sq ft Training & Innovation Center to enhance customer experience and support
- Expansion of Waltham site to 182,000 sq ft, including new OPUS® warehousing space
- Completion of 80,000 sq ft LEED Silver certified facility in Jüri, Estonia, expanding European presence
- None.
Insights
The opening of Repligen's Training & Innovation Center (RTIC) represents a significant strategic move to enhance customer engagement and support in the bioprocessing industry. This 7,500 square foot facility showcases Repligen's full range of technologies, from upstream intensification to downstream processing and fluid management.
The RTIC's impact extends beyond mere product display. It serves as a hands-on training ground for customers and technical teams, potentially accelerating adoption of Repligen's solutions and strengthening customer relationships. This investment in customer experience could translate to increased sales and market share in the long term.
Coupled with the recent expansion in Estonia, Repligen is positioning itself for anticipated market growth in 2025. The focus on innovation and customer support aligns well with the expected expansion in the biologics market. However, investors should note that while these developments are positive, they may not have an immediate impact on financial performance.
Repligen's strategic investments in customer-facing infrastructure signal confidence in the bioprocessing market's future growth. The company's expansion efforts, both in Waltham and Estonia, are aligned with industry trends towards increased biologics production and the need for advanced bioprocessing solutions.
The 55,000 square foot expansion in Waltham, primarily dedicated to OPUS® warehousing, suggests Repligen is preparing for increased demand. This, combined with the new 80,000 square foot facility in Estonia, significantly boosts Repligen's operational capacity and geographic reach.
Investors should view these developments as part of a long-term growth strategy. While the immediate financial impact may be , these investments position Repligen to capitalize on the expected market upturn in 2025. The focus on customer experience and technical support could also lead to improved customer retention and potentially higher margins in the future.
WALTHAM, Mass., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the grand opening of its Repligen Training & Innovation Center (“RTIC”) at its Waltham headquarters. The opening celebration, held on the evening of September 23, attracted a group of over 150 biopharma and CDMO customers. The RTIC buildout, which features product exhibits, purpose-built demonstration areas and technical training space, was designed to provide customers with pre- and post-sales support, and provide a hands-on experience with Repligen’s innovative bioprocessing solutions.
The RTIC enables the functional display of all Repligen bioprocessing technologies; a complete collection from across the company’s global manufacturing sites. Upstream intensification technologies include XCell® ATF and KrosFlo® TFDF® devices and controllers. Downstream products include OPUS® pre-packed chromatography columns, consumables such as Spectrum® hollow fiber filters, TangenX® flat sheet cassettes and devices, and affinity resins. Representing the company’s equipment/consumables integration strategy, there will be a number of systems on permanent display, including KRM™ Chromatography, KrosFlo® RS TFF, KrosFlo® KR2i RPM™, and KrosFlo® FS systems. The CTech™ SoloVPE® and FlowVPX® line of process analytics technologies will also be highlighted. In the area of Fluid Management, products include ProConnex® MixOne carboys systems and flow paths, Metenova magnetic mixers, non-metallic equipment and a number of valve, clamp and tubing technologies.
Olivier Loeillot, President and Chief Executive Officer of Repligen said, “We’re just thrilled to be opening this Center to elevate the customer experience through live engagement with our subject matter technology experts. The RTIC will demonstrate our end-to-end capabilities, and provide workshops and training grounds for our technical teams and customers. The completion of RTIC represents our unwavering commitment to innovation and sets us up well to meet and exceed customer expectations as we set our sights on 2025 and an expected return to growth on the underpinnings of a strong and expanding biologics market.”
Construction of the RTIC was completed in partnership with the site landlord as part of a broader expansion project over a 20-month period. The RTIC occupies approximately 7,500 square feet of the 55,000 square foot expansion, with the remaining space primarily dedicated to OPUS® warehousing. In total, the Waltham site occupies 182,000 square feet.
In addition to the RTIC opening, the company earlier this year (May) completed a site relocation and expansion in Jüri, Estonia, a milestone in Repligen’s commitment to broadening its presence and enhancing its capabilities in European and global bioprocessing markets. The world-class 80,000 square foot facility is leased to house Repligen’s advanced TFF and chromatography systems and technologies, and to serve as a strategically situated Customer Center of Excellence. Activities at the site include R&D, engineering, manufacturing, sales, service and technical support. The facility is LEED Silver certified and embodies Repligen’s commitment to environmental stewardship and corporate responsibility.
About Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. We are “inspiring advances in bioprocessing” for the customers we serve; primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Our focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Our corporate headquarters are in Waltham, Massachusetts, and the majority of our manufacturing sites are in the U.S., with additional key sites in Estonia, France, Germany, Ireland, the Netherlands and Sweden. For more information about the company see our website at www.repligen.com, and follow us on LinkedIn.
Forward Looking Statements
This press release may contain forward-looking statements within the meaning of the federal securities laws. Investors are cautioned that statements in this press release which are not strictly historical statements including, without limitation, statements identified by words like “believe,” “expect,” “may,” “will,” “should,” “seek,” or “could” and similar expressions, constitute forward-looking statements. Such forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including risks discussed from time to time in our filings with the Securities and Exchange Commission. We expressly disclaim any responsibility to update any forward-looking statements, except as required by law.
Repligen Contact:
Sondra S. Newman
VP, Global Head of Investor Relations
(781) 419-1881
investors@repligen.com
FAQ
What is the size of Repligen's new Training & Innovation Center (RTIC) in Waltham?
When did Repligen (RGEN) open its new Training & Innovation Center?
What technologies are showcased at Repligen's (RGEN) new Training & Innovation Center?
Where did Repligen (RGEN) recently complete a site relocation and expansion in Europe?
